Keel Point’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Keel Point’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-2,500	Closed	-$283K	–	128
2015 Q4	$283K	Sell	2,500 -398	-14%	-$42.9K	0.15%	102
2015 Q3	$294K	Sell	2,898 -60,398	-95%	-$7.18M	0.16%	82
2015 Q2	$7.93M	Buy	63,296 +274	+0.4%	+$33.1K	3.78%	4
2015 Q1	$7.45M	Buy	+63,022	New	+$7.12M	3.74%	4

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Keel Point's FBT Position: Q1 2016 in Review

Keel Point sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q1 2016, closing a stake of 2,500 shares — an estimated $283K sold.

Keel Point first reported a position in FBT in Q1 2015 and held it in 4 quarters. The position peaked at $7.93M in Q2 2015. 107 funds tracked by Wall St. Rank hold FBT as of Q1 2016.

Keel Point reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q1 2016 after selling out during the quarter.
Keel Point sold 2,500 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2016, an estimated $283K.
Keel Point first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2015 and held it in 4 quarters.
Keel Point's First Trust NYSE Arca Biotechnology Index Fund position peaked at $7.93M in Q2 2015.
107 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2016.

Based on Keel Point's 13F filing for Q1 2016, filed 13 May 2016.